<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Steinberg, Jonathan S.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Reablation Superior to Antiarrhythmic Drug Therapy after a Failed Ablation Procedure</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">22-23</style></pages><abstract><style  face="normal" font="default" size="100%">A second catheter ablation is superior to antiarrhythmic drug (AAD) therapy for reducing the progression and prevalence of atrial fibrillation (AF) after an initial failed pulmonary vein isolation ablation for paroxysmal AF. In this randomized comparison of reablation and AAD therapy, progression to AF was substantial and progression to persistent AF not uncommon with AAD therapy but much less after redo ablation.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">13</style></volume></record></records></xml>